Note on labeling: the events below come from r/peptides, r/PeptideTherapy, and forum sources for research-peptide oral or subcutaneous 5-amino-1MQ use
The estimated lifetime prevalence of binge eating disorder and bulimia nervosa worldwide is 1.9% and 1%, respectively
Semaglutide and liraglutide were derived from the native structure of GLP-1
This improved circulation supports enhanced sensitivity and responsiveness in intimate areas
In obese individuals, weight loss and exercise have been shown to completely reverse insulin resistance and type 2 diabetes
An accompanying commentary by Bain and Min (2023) explores the development of incretin drugs for both glycaemic management and weight reduction, and calls for the phase 3 trials of retatrutide to include higher-dose GLP-1 and dual GIP/GLP-1 receptor agonists as active comparators, rather than dulaglutide 1.5 mg